Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer? [electronic resource]
Producer: 19950309Description: 357-62 p. digitalISSN:- 0007-0920
- Adult
- Aged
- Antibodies, Monoclonal -- immunology
- Antigens, Neoplasm -- analysis
- Biomarkers, Tumor -- analysis
- Carboplatin -- therapeutic use
- Cell Division
- Combined Modality Therapy
- England -- epidemiology
- Female
- Humans
- Immunoenzyme Techniques
- Laparotomy
- Life Tables
- Middle Aged
- Neoplasm Staging
- Neoplasm, Residual
- Ovarian Neoplasms -- chemistry
- Paraffin Embedding
- Prognosis
- Proliferating Cell Nuclear Antigen -- analysis
- Radiotherapy, Adjuvant
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.